Viridian Therapeutics
VRDN
VRDN
57 hedge funds and large institutions have $71M invested in Viridian Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Holders
57
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.18M | |
| 2 | +$2.01M | |
| 3 | +$1.09M | |
| 4 |
SG Americas Securities
New York
|
+$517K |
| 5 |
State Street
Boston,
Massachusetts
|
+$373K |
Top Sellers
| 1 | -$3.21M | |
| 2 | -$2.76M | |
| 3 | -$164K | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$142K |
| 5 |
SIM
Spark Investment Management
New York
|
-$64K |